GAD2 and lung carcinoma: Five of these patients suffered from lung cancer (4 with anti-GABABR-Ab and one with anti-GAD65-Ab), one patient with anti-GABABR-Ab had colon cancer, one patient with anti-GABAAR-Ab had thymoma, and one with anti-GlyR-Ab had breast cancer.